In fact, selective σ2R ligands preferentially bind to pancreatic adenocarcinomas; thus, expanding the possibility of σ2R-based applications in diagnostic imaging, in addition to therapy (110) or drug development (239). This evidence concerns the gene TMEM97 and pancreatic adenocarcinoma.